Physician profile
Sonja Carroll
NPI 1457520603
$985.90
in general payments reported to CMS, 2019-2025
12 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.35 · 2022: $129 · 2023: $150 · 2024: $197 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $282.77 | 2022-2025 | Talvey, Rybrevant |
| Daiichi Sankyo INC. | $227.49 | 2021-2025 | Datroway, Enhertu |
| Celgene Corporation | $130.64 | 2023-2025 | Reblozyl |
| Pharmacosmos Therapeutics INC. | $81.51 | 2022-2024 | Monoferric |
| Genentech USA, INC. | $58.05 | 2023-2025 | Tecentriq, Columvi, Itovebi |
| Incyte Corporation | $54.98 | 2024-2025 | Jakafi |
| Geron Corporation | $42.05 | 2025 | Rytelo |
| Astrazeneca Pharmaceuticals LP | $28.63 | 2025 | |
| Astellas Pharma US INC | $21.51 | 2025 | Vyloy |
| Novartis Pharmaceuticals Corporation | $20.27 | 2025 | |
| Abbvie INC. | $20.08 | 2023 | |
| Alexion Pharmaceuticals, INC. | $17.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonja Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.